420 with CNW – Data Confirms that Cannabis Sales Were Boosted on 420

Data collected shows that cannabis sales were higher on 4/20 in line with the predictions that had been made regarding the effect of the marijuana “holiday” on sales. Headset, a cannabis industry analysis company, had initially predicted a 100 percent increase in sales on that day.

The data that they collected shows that marijuana sales on 4/20 actually exceeded what had been predicted since sales increased 128 percent when compared to the volume of sales registered on the previous four Saturdays.

The report released by Headset also shows that the “eve” of 4/20 was also good for cannabis retailers since sales increased by 27 percent when compared to the sales of the previous four Fridays. Historical data shows that Fridays are normally good days for cannabis businesses, so the fact that this particular Friday happened to be the “eve” of 4/20 provided an added reason for marijuana users to open their wallets.

The report released by Headset was based on real-time data collected via the POS (point-of-sale) systems of cannabis retailers who agreed to link their systems to the data analytics system of Headset.

In terms of sales data from different states, shoppers in Maryland spent the most on cannabis on 4/20 because the average shopper spent approximately $105 before tax on that day. Shoppers in Oregon spent the least amount on that day, with the average amount spent by each buyer totaling just $36. More mature cannabis markets like Colorado and Nevada saw the average expenditure being about $50 while this figure jumped to $76 when the data on the largest marijuana market in the world (California) was analyzed.

In terms of experience level, just 25 percent of buyers where beginners while the majority of the people who bought cannabis on 4/20 were intermediate users of pot.

Two-thirds of marijuana shoppers on the holiday were people aged between 21 and 34 years of age. Senior citizens (aged 55 and above) only took 4 percent of the population of cannabis shoppers on that day.

More than half of all cannabis buyers bought cannabis flower while a third of the buyers purchased cannabis concentrates. Marijuana edibles completed the list of the products most bought on 4/20.

A further analysis shows that the most popular items on that day were the products that could be consumed as soon as a shopper left a dispensary or retail outlet. Cannabis beverages therefore registered a 136 percent growth rate when compared to other products.

Global Payout Inc. (OTC: GOHE) and Geyser Brands Inc. (TSX.V: GYSR) are pleased to learn that the findings of the sales data on 4/20 shows that despite increasing legalization across the U.S., cannabis hasn’t lost its novelty among buyers.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Canada Preparing to Approve Second Cannabis Roadside Test Kit

The Canadian government is close to approving a second cannabis test set for use by law enforcement officers who suspect that a driver may be impaired by marijuana. The kit uses a sample of saliva to test for the presence of THC in the body of an individual flagged down for possible marijuana impairment.

The Department of Justice had earlier issued an order on April 20 to add the three pieces of equipment made by Abbot to the equipment that the police can use to get preliminary results when they suspect that someone is driving while impaired after consuming marijuana.

The three pieces of “SoToxa” equipment are used together during roadside cannabis testing. The first component is used to collect a saliva sample, the second component holds that sample while the third tests the saliva collected for THC (the psychoactive component of marijuana).

According to the Department of Justice in Canada, a positive test result would give a strong indication that the driver had recently used marijuana.

The law enforcement officer can then take the next step in the process, which is to arrest the driver and take a blood sample so that comprehensive drugs testing can be done before the person is charged.

The company which makes the SoToxa equipment claims that their test kit is easier to use and produces results faster than any other roadside test kit currently available on the market.

The SoToxa and other similar products have been introduced on the Canadian market after the country passed a law on impaired driving at the same time as the passing of the law which legalized recreational cannabis in Canada.

Currently, the fate of the SoToxa test kit may be in the hands of the public since the government has opened a 30-day window within which members of the public can review the equipment and provide feedback about its usefulness.

The kit will be approved once the feedback from the public is considered no serious defects are unearthed.

However, the issue of testing drivers for impaired driving still seems to be shrouded in controversy. For example, a commission in Michigan recently recommended that no THC limit should be indicated as the threshold to determine that someone is impaired. Several reasons were given, such as there being no scientific data to establish what concentration of THC in the blood results in impairment.

One would therefore be prompted to wonder upon what basis the Canadian government came up with a THC limit for one to be guilty of driving under the influence of marijuana.

Global Payout Inc. (OTC: GOHE) and Geyser Brands Inc. (TSX.V: GYSR) hope that the roadside tests will catch truly impaired drivers rather than those whose bodies still contain cannabis metabolites long after the person used marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – New Jersey Lawmakers Remain Undecided as Governor Sets Cannabis Legalization Deadline

Approximately a month ago, a vote in the New Jersey senate on a bill to legalize recreational cannabis was postponed after it was realized that the bill may not have enough support among the senators. Now Gov. Murphy has given the legislators up to the end of May to pass the bill or he would use his executive powers to expand the medical cannabis program.

Insiders say that the biggest sticking point is the matter of who qualifies to have their cannabis-related criminal record expunged.

The bill sets the marijuana possession limit at 5 pounds if someone is to have their criminal record erased. Some lawmakers are suffering from “sticker shock” at that number because they think that such a high limit will allow hardened drug dealers to benefit from this law.

However, supporters of the law say that the 5-pound marijuana possession limit is fair, and many of the people who qualify to have their records expunged have already served their jail sentences.

The supporters therefore say that it is hypocritical for New Jersey to collect money from recreational marijuana while continuing to “punish” those who were convicted for possessing the same marijuana that the state is collecting taxes from.

The advocates say ex-convicts should have a chance to rebuild their lives by getting jobs, buying homes and doing any other thing that other residents can easily do without being encumbered by a criminal past related to cannabis possession.

This now sets up the state for a classic catch-22 situation because the framers of the marijuana legalization bill may never convince other senators to support the bill if the limit remains at 5 pounds while some supporters will jump ship if the limit is lowered to accommodate what some Republicans and even Democrats are demanding.

It is believed that the bill needs 1-4 additional votes to pass. Those four votes are turning out to be a huge mountain to climb, yet the clock is ticking on the deadline set by the Governor who came to office having promised to legalize marijuana within his first year at the top.

If a vote doesn’t take place by end of May, then it may be pushed to December after new lawmakers are elected. For now, the Senate leader and other top leaders are scrambling to find a solution to the impasse so that the law can be passed as soon as possible.

The cannabis industry, including Global Payout Inc. (OTC: GOHE) and Golden Developing Solutions Inc. (OTC: DVLP), is holding its breath hoping that a solution is found quickly so that the intended beneficiaries of the law don’t have to wait for longer than is absolutely necessary.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Georgia on the Verge of Legalizing Medical Cannabis

The state assembly in Georgia has passed a bill that will allow medical marijuana to be grown and processed within the state. With the Governor ready to sign the bill, there seems to be no hurdle to medical marijuana becoming a reality.

HB 324 was drafted in order to address the gaps that were created by a law passed in 2015 legalizing the use of low-THC cannabis oil for the treatment of a given set of medical conditions.

However, that law didn’t create any provision for the cultivation, sale or possession of cannabis oil within Georgia.

The bill that has just been passed addresses all those loopholes. It creates avenues through which cannabis can be grown for the extraction of low-THC marijuana oil. The bill also allows the creation of a commission to oversee the medical cannabis industry, as well as license different entities like universities which wish to take part in the manufacture of cannabis oil.

HB 324 doesn’t legalize recreational cannabis in the state, and it doesn’t have any provisions that allow the smoking of cannabis within the state.

It has been reported that Governor Kemp did a lot to help the assembly and the senate to reach a consensus on how the illegal distribution of marijuana will be prevented in the state. This compromise paved the way for the passing of HB 324.

Kemp said, “I have met several kids struggling with debilitating diseases, as well as parents who are losing hope that their kids can be helped. Medical cannabis offers hope to such parents.”

Kemp added that legalizing medical marijuana was the right thing to do, and that was why he invested so much in seeing to it that both legislative houses approved the bill.

If the bill is finally enacted into law, Georgia will join the long list of 33 states that have legalized medical marijuana.

Advocates may not be happy that the state is only allowing the use of cannabis oil, but it is at least a good start. Reforms can be introduced later when the program is being implemented and the patients, as well as the regulators, realize that other forms of cannabis, such as creams and edibles, may be needed.

All in all, the entire cannabis industry, especially Global Payout, Inc. (OTC: GOHE) and Golden Developing Solutions, Inc. (OTC: DVLP) congratulate the lawmakers in Georgia for making it possible for patients to have one more treatment option as those patients battle with the conditions afflicting them.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Why New Jersey Marijuana Legalization Bill Vote May Have Been Called Off

On March 25, the planned vote on a marijuana legalization bill in New Jersey was suddenly called off by both legislative houses in a move that disappointed cannabis advocates who had thought that the bill would sail through. Here are some possible reasons for the cancellation of the vote.

Insufficient Time to Convince Legislators

The legalization bill was released by the different committees less than a fortnight before a final vote was scheduled by the two houses.

This time was too little for advocates to convince legislators to support the bill. Consequently, Senate President Sweeney thought it wise to cancel the vote rather than take a risk and the bill fails to garner the required number of “yes” votes.

Strong Resistance Among Democrats

From the time Gov. Murphy made legalizing marijuana a priority of his term in office, there were a number of Democratic legislators that vowed not to support the legalization process.

These senators included Fred Madden (D-Gloucester), Richard Codey (D-Essex), Ronald Rice (D-Essex) and so many others. To compound this opposition, other Democratic senators joined those opposing the bill late during the legalization process.

This opposition from within the Democratic camp made it even more urgent to rally some Republican senators for the cause, but as earlier mentioned, there wasn’t enough time for this.

Last-Minute Changes Unsettled Some Legislators

Another possible reason why voting on the legalization bill was called off is because there were some changes that were made to the bill in the committees just before it was sent to be voted on by all legislators in the different houses. These changes weren’t agreeable to all supporters, especially in the state senate.

Of particular concern were changes that were introduced on matters of expunging the criminal records with respect to cannabis arrests and convictions.

Some legislators who would have voted for the bill were dismayed when they discovered that the threshold for possession was set at five pounds for those to benefit from the expungement provisions. This was unacceptable to these legislators and some decided to switch from supporting the bill to opposing it.

So, what happens next?

There is hope that the bill may be reconsidered for a vote before June 30 when the next budget of the state is due to be passed. If that doesn’t happen, then legalization may be delayed by another year or until another set of legislators is voted into office.

The cannabis industry, including Global Consortium, Inc. (OTC: GCGX) and Global Payout, Inc. (OTC: GOHE) hope that the current wave of support for cannabis legalization in the public and among the legislators results in a speedy passing of this bill.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Delaware Considers Letting Doctors Prescribe Cannabis for Most Ailments

Senator Anthony Delcollo has introduced a bill in the state senate to change the law so that doctors will be free to decide which patient would be helped by medical marijuana instead of first checking whether that patient has a condition listed in the medical marijuana law.

Under the current law which was passed in 2011, patients can only qualify to get onto the medical marijuana program if they have one of the “debilitating conditions” such as terminal illnesses and cancer.

Delcollo argues that doctors undergo extensive training and have a lot of experience in the field. These professionals should be given the liberty to decide what is in the best interest of their patients, he says.

Senate Bill 24 is therefore intended to free doctors to use their discretion in determining whether medical cannabis will provide “palliative or therapeutic benefit” to patients.

The senator argues that this wouldn’t be a new thing since doctors are already exercising their professional discretion to determine which pharmaceuticals on the market are most likely to be beneficial to their patients.

Medical cannabis advocates concur and say that the proposed change is long overdue. They add that it should have been part of the first law that legalized medical marijuana in the state in 2011.

The bill is also intended to ease the restrictions on the kinds of medical specialists that are authorized to recommend the use of medical cannabis by patients who are younger than 18. However, the change would not alter the current provision stating that patients who are less than 18 can only use cannabis oil and not any other form of medical marijuana.

Senate Bill 24 enjoys bipartisan sponsorship and support, so it is hoped that the lawmakers will debate it thoroughly and give it the nod.

If it passes, Delaware will join Oklahoma and Maine as the only states that give doctors such leeway in deciding who can or cannot be treated using medical marijuana.

It hasn’t been an easy journey for Delaware to get to this point. It should be recalled that there were endless delays in opening the compassion centers where patients could access medical cannabis. To date, only four such centers are operational in the state.

More recently, there were plans to legalize recreational marijuana legislatively. More than a year was taken to debate the bill and when a vote was called, the bill was defeated by just four votes in June last year. No other recreational marijuana bill has yet been tabled during this legislative session.

Be that as it may, Global Payout, Inc. (OTC: GOHE), Golden Developing Solutions, Inc. (OTC: DVLP) and the entire investment community are hoping that this time round, appropriate legislation improving the medical cannabis environment is passed so that all interested parties, such as patients, can benefit.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – New Hampshire House Committee Okays Medical Cannabis Home-Grows

As momentum gathers to legalize recreational cannabis in New Hampshire, a House committee has passed a bill permitting patients enrolled on the medical cannabis program to grow their own marijuana, as well as other measures intended to expand the medical marijuana program.

The Human Services and Elderly Affairs Committee of the New Hampshire Assembly voted on Tuesday last week to allow patients or their caregivers to have three mature cannabis plants, three immature plants as well as 12 seedlings of cannabis.

The bill also included a raise on the cap of medical marijuana that a patient could have from 6 to 8 ounces.

The move to allow patients to grow their own cannabis and also possess higher amounts of the substance is intended to ease the inconveniences that some patients in distant locations were facing in accessing one of the four medical marijuana dispensaries run by the state.

The contents of the bill are also intended to allow patients to customize their medical cannabis without incurring a high cost. For example, one patient (Heather Marie Brown) revealed that she spends $400 each month on medical cannabis to treat PTSD. However, with home-grows now set to be allowed, she will spend approximately $150 to grow all the cannabis she needs for her condition.

There were calls for the committee members to increase the number of qualifying conditions, but this wasn’t acted on because the lawmakers felt that it was premature for them to make a decision on that matter yet a special committee of medical experts set up to advise the State on the qualifying conditions is scheduled to meet this month (March) to discuss that same matter.

One of the qualifying conditions that was being considered for addition to the list is opioid addiction. However, many legislators were hesitant to approve its inclusion because there was insufficient evidence that cannabis could wean people off prescription opioids. Other lawmakers didn’t think it would be good to recommend the use of one potentially addictive substance as a replacement for another addictive substance/drug.

Meanwhile, the entire House is scheduled to vote on a proposal to legalize recreational marijuana across the state. Previous attempts to get recreational cannabis legalized in the state met with dismal failure, but hopes of success are high this time round since Democrats now have control of both the Senate and the Assembly.

For the sake of the patients and the general population in New Hampshire, Global Payout Inc. (OTC: GOHE) and Golden Developing Solutions Inc. (OTC: DVLP) wish for a speedy conclusion to the different bills before the legislators.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – New York City Legislators Consider Banning Pre-Employment Cannabis Tests

New York Governor Andrew Cuomo has outlined his plan to legalize recreational marijuana and this has put New York in pole position to become the 11th state where adult-use cannabis is legal. This development has prompted some lawmakers in New York City to draft a bill that seeks to ban employers from conducting marijuana drugs tests before hiring an employee.

Councilman Jumaane D. Williams is the NYC lawmaker who has filed a draft law that will stop marijuana tests from being part of the hiring process in the city.

Councilman Williams feels that the legislators and the city should be creating more avenues through which people can find jobs, but the drugs tests do the opposite by making it harder for jobseekers to get hired.

He adds that pre-employment drugs tests for marijuana should be done away with now that preparations were in advanced stages to legalize recreational cannabis. Why should employers continue to test prospective employees for a substance that will soon legal?

The bill tabled by Williams provides exceptions to this ban on pre-employment drugs tests. People who intend to get jobs where safety and security are paramount, as well as jobs with the federal government or its agencies would not be covered by this ban on pre-employment drugs tests. Additionally, individuals who are required to undergo drugs testing as a condition for securing a grant or contract from the federal government will not use this local law as a reason to skip the required drugs tests.

If passed, the bill will take effect one year from the time of its enactment as part of the city’s laws. This will remove the ambiguity that has been observed in various jurisdictions, such as Massachusetts, where marijuana is legal but an employee can still be fired for testing positive for THC.

It is good that the lawmakers in New York City have been proactive in tabling this bill instead of waiting to take action after recreational cannabis becomes legal across the state. In such a case, there would be a legal grey area since the existing laws permit pre-employment marijuana tests, which would run counter to the freedom granted by the law legalizing recreational pot.

It remains to be seen what form the final bill will take once the Committee on Civil and Human Rights discusses it and presents it to the full council for debate and a vote. Generation Alpha Inc. (OTCQB: GNAL), Global Payout Inc. (OTC: GOHE) and the whole marijuana industry say kudos to Councilman Williams and the other two co-sponsors of this reform that will remove the ambiguity regarding the use of legal cannabis and its effects on one’s prospects of getting hired.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Baby Boomers are a Growing Cannabis Market

Statistics have it that baby boomers are a rapidly growing market segment in the cannabis industry, and any firm looking to get a foothold in this industry needs to pay attention to this demographic.

Why This Group Matters

First, baby boomers are no longer taking care of kids, and many are approaching retirement. This means that this group has accumulated some resources and they have disposable income that they can spend on cannabis. Who wouldn’t want a potential client that has money to spend?

Secondly, cannabis isn’t an altogether new substance to these people. Many of them sampled the product or know someone who did during their younger years. It will therefore not be as if you are starting from scratch if you want to get these people to buy your cannabis products.

Thirdly, baby boomers tend to be brand-loyal, so it makes sense to get to them early before a competitor wins their loyalty. Getting them to switch from one brand to another can be a monumental undertaking that you don’t want to attempt.

Crucially, many baby boomers have health conditions for which medical cannabis can be a viable solution. For example, arthritis and chronic pain plague a significant fraction of this demographic. Positioning your products as the products to ease their pains and alleviate other ailments can pay off in a big way.

How to Get Your Foot In

Each demographic has its own unique characteristics that businesses must understand in order to win their patronage. For starters, baby boomers are more likely to pay attention to word of mouth recommendations when compared to other marketing efforts. Crack this method and you will have them buying from you in droves.

Another way to get this demographic is by making it easy for them to access your products. Many among them have mobility challenges while some may be concerned about keeping their cannabis use discreet. Home delivery and shuttle services can address these concerns and boost your sales.

Additionally, this group is what some may call “old fashioned.” Product information should be given to them during face-to-face interactions, especially at the dispensary or retail outlet. Cannabis businesses that are designed to make this possible will get a sizeable share of the clientele in this group.

The cannabis industry, especially Generation Alpha Inc. (OTCQB: GNAL) and Global Payout Inc. (OTC: GOHE) will definitely find ways to meet all the needs of the different age groups, including the baby boomers.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Israeli Cabinet Approves Export of Marijuana Products

Toward the end of last year, we reported that the Israeli parliament had passed a bill permitting local companies to export medical marijuana. However, there were fears that the cabinet may wait until after elections before pronouncing itself on this matter. It turns out that those concerns were premature because the cabinet has given its approval and cannabis firms can start processing the necessary paperwork to sell medical cannabis abroad.

The cabinet’s decision leaned on the recommendations made by an inter-ministerial committee (finance and health ministries) that was tasked with studying the Act of parliament and then advise the cabinet on the matter.

The committee took note of the advanced research, technology and regulatory capabilities of the country as major advantages that would make Israeli medical cannabis competitive on the world market.

The worldwide medical cannabis market is growing rapidly from an estimated valuation of $8.3bn in 2017 to about $28bn by 2024. Medical cannabis exports would earn Israeli firms about $1.09bn each year.

The Ministry of Finance agreed to channel some of the money earned from cannabis exports to the Ministry of Health.

Currently, there are eight companies that grow medical cannabis in Israel. The approval of exports is good news to them because the domestic market wasn’t large enough to sustain these producers as well as those who are still queuing to get licenses.

Medical cannabis exports will be tightly regulated since cannabis is a drug that is subject to strict controls internationally. Israeli companies will get an export permit issued by the Ministry of Health and approved by the police. These companies will then export medical cannabis to other companies in Europe. Those companies should have also obtained permits to import medical cannabis.

Israel is likely to enjoy several advantages when compared to other countries, such as Canada, that export medical cannabis. For example, Israel is closer to most European markets when compared to its competitors.

Secondly, Israel is renowned for having very strict regulatory systems and its research capabilities are famous across the world. This makes Israeli medical cannabis exports to have a good reputation on the market when compared to other exporters whose domestic regulatory mechanisms aren’t so rigorous.

As you can see, different countries are positioning themselves to control a large share of the international medical cannabis market. The question is, when will the U.S. wake up and catch up with the other countries that are already active in the medical cannabis space? The sooner federal marijuana laws are reformed, the better for the U.S. cannabis industry. This speedy legal reform is what entities like Golden Developing Solutions, Inc. (OTC: DVLP) and Global Payout, Inc. (OTC: GOHE) have been hoping to see for years.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com